BioVie Inc. (BIVI) vs Cerenome, Inc. (CNSY)

A side-by-side comparison of BioVie Inc. and Cerenome, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BIVI

BioVie Inc.

$11M

$1.44HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

CNSY

Cerenome, Inc.

$11M

$1.59HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — BIVI vs CNSY

growth of $100 · dividends reinvested · last 1y

BIVI -26.2% (-26.2%/yr)CNSY -61.5% (-61.5%/yr)BIVI compounded faster over this window

BIVI CNSY

BIVI vs CNSY: by the numbers

•CNSY is the larger company ($11M vs $11M market cap).
•Both run net losses; BIVI's is the smaller (0.00% vs -620.70% net margin).

Metrics side by side

Valuation

Metric	BIVI	CNSY
P/S ratio	N/A	2.60
P/B ratio	1.06	2.00

Profitability

Metric	BIVI	CNSY
Gross margin	0.00%	89.58%
Operating margin	0.00%	-293.46%
Net margin	0.00%	-620.70%
ROE	-214.92%	-477.54%
ROIC	-216.67%	-479.39%

Growth (annualized)

Metric	BIVI	CNSY
Total return CAGR (5Y)	-70.37%	N/A

Go deeper

Full BIVI analysis Full CNSY analysis Interactive comparison tool

Dig into the metrics

BioVie ROE Cerenome ROE BioVie operating margin Cerenome operating margin BioVie revenue growth Cerenome revenue growth BioVie free cash flow Cerenome free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.